The Price of Adherence: Qualitative Findings From HIV Positive Individuals Purchasing Fixed-Dose Combination Generic HIV Antiretroviral Therapy in Kampala, Uganda
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Contrary to early expectations, recent studies have shown near-perfect adherence to HIV antiretrovirals in sub-Saharan Africa We conducted qualitative interviews with patients purchasing low-cost, generic antiretroviral therapy to better understand the social dynamics underlying these findings. We found that concerns for family well-being motivate adherence, yet, the financial sacrifices necessary to secure therapy may paradoxically undermine family welfare. We suggest that missed doses may be more due to a failure to access medication rather than a failure to adhere to medications, and that structural rather than behavioral interventions may be most useful to insure optimal treatment response.
- Bangsberg, D. R., and Deeks, S. G. (2002). Is average adherence to HIV antiretroviral therapy enough? Journal of General Internal Medicine, 17(10), 812–813. CrossRef
- Byakika-Tusiime, J., Oyugi, J. H., Tumwikirize, W. A., Katabira, E. T., Mugyenyi, P. N., and Bangsberg, D. R. (2005). Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. Int. J. STD. AIDS. 16(1), 38–41.
- Farmer, P., Leandre, F., Mukherjee, J., Gupta, R., Tarter, L., and Kim, J. Y. (2001). Community-based treatment of advanced HIV disease: Introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy). Bulletin of the World Health Organization, 79(12), 1145–1151.
- Glaser, B., and Straus, A. (1967). The discovery of grounded theory: Strategies for qualitative research. Chicago: Aldine.
- Harries, A. D., Nyangulu, D. S., Hargreaves, N. J., Kaluwa, O., and Salaniponi, F. M. (2001). Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet, 358(9279), 410–414. CrossRef
- Laurent, C., Kouanfack, C., Koulla-Shiro, S., Nkoue, N., Bourgeois, A., Calmy, A., Lactuock, B., Nzeusseu, V., Mougnutou, R., Peytavin, G., Liegeois, F., Nerrienet, E., Tardy, M., Peeters, M., Andrieux-Meyer, I., Zekeng, L., Kazatchkine, M., Mpoudi-Ngole, E., Delaporte, E. (2004). Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Lancet, 364(9428), 29–34. CrossRef
- Liechty, C. A., and Bangsberg, D. R. (2003). Doubts about DOT: antiretroviral therapy for resource-poor countries. AIDS, 17(9), 1383–1387. CrossRef
- Miles, M., and Huberman, A. (1994). Qualitative Data Analysis: An Expanded Sourcebook. Thousand Oaks, CA: Sage.
- Orrell, C., Bangsberg, D., Badri, M., and Wood, R. (2003). Adherence is not a barrier to delivery of HIV antiretroviral therapy in resource-poor countries. AIDS, 17(9), 1369–1375. CrossRef
- Oyugi, J. H., Byakika-Tusiime, J., Charlebois, E. D., Kityo, C., Mugerwa, R., Mugyenyi, P., et al. (2004). Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquired Immune Deficiency Syndromes, 36(5), 1100–1102. CrossRef
- Stevens, W., Kaye, S., and Corrah, T. (2004). Antiretroviral therapy in Africa. Bmj, 328(7434), 280–282. CrossRef
- Whyte, S., Whyte, M., Meinert, L., and Kyaddondo, B. (2004). Treating AIDS: Dilemmas of unequal access in Uganda. Journal of Social Aspects of HIV/AIDS Research Alliance, 1(1), 14–26.
- The Price of Adherence: Qualitative Findings From HIV Positive Individuals Purchasing Fixed-Dose Combination Generic HIV Antiretroviral Therapy in Kampala, Uganda
AIDS and Behavior
Volume 10, Issue 4 , pp 437-442
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- generic fixed-dose combination antiretroviral therapy
- Industry Sectors
- Author Affiliations
- 1. Department of Anthropology, History and Social Medicine, UCSF, San Francisco, California, USA
- 2. Epidemiology and Prevention Interventions Center, Division of Infectious Diseases, San Francisco General Hospital, UCSF, San Francisco, California, USA
- 3. Academic Alliance for AIDS Care and Prevention, Kampala, Uganda
- 4. Makerere University School of Medicine, Kampala, Uganda
- 5. Department of Epidemiology and Biostatistics, UCSF, San Francisco, California, USA
- 6. Positive Health Program, San Francisco General Hospital, UCSF, San Francisco, California, USA
- 7. University of California at San Francisco, Epidemiology and Prevention Interventions Center, SFGH Building, 100 Room 301, PO Box 1347, San Francisco, California 94143, USA